Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7273
    +0.0010 (+0.14%)
     

  • CRUDE OIL

    83.34
    +0.61 (+0.74%)
     

  • Bitcoin CAD

    87,815.15
    +530.06 (+0.61%)
     

  • CMC Crypto 200

    1,380.29
    +67.67 (+5.34%)
     

  • GOLD FUTURES

    2,404.50
    +6.50 (+0.27%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6823
    +0.0002 (+0.03%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON TECH DRAG

Nvidia tumbles 10%, Amazon loses more than 2% while Apple ends 1% lower

We're Proud to Have Supported a Special Issue of Tuskegee University's Journal of Healthcare, Science, and the Humanities

News Direct
·1 min read

Featured articles and commentaries explore social, cultural and economic factors related to HIV/AIDS in the Black Community

Northampton, MA --News Direct-- Gilead Sciences

We’re proud to have supported a special issue of Tuskegee University’s Journal of Healthcare, Science, and the Humanities. The issue highlights factors that have historically driven the disproportionate impact of HIV on Black communities, and it outlines policy and programmatic solutions to help eliminate disparities.

About Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

ADVERTISEMENT

Originally Publiched by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/were-proud-to-have-supported-a-special-issue-of-tuskegee-universitys-journal-of-healthcare-science-and-the-humanities-756134294